Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Monitoring suspected toxicity
Detecting possible abuse
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that
also has antipyretic and analgesic activities. The anti-inflammatory
activity is explained in part by the drug's ability to inhibit prostaglandin
synthesis. Approximately 80% of an oral dose is absorbed.
Ibuprofen is eliminated predominantly by hepatic metabolism
with <10% of the drug being excreted unchanged in urine. The
elimination half-life is short (2-4 hours); metabolism and excretion
are essentially complete within 24 hours after an oral dose.
Adverse reactions occurring in 3-9% of users include nausea,
epigastric pain, heartburn, dizziness, and skin rash. Adverse
reactions affecting <3% of users include vomiting, diarrhea,
gastric or duodenal ulcer, nervousness, blurred vision, and edema.
As with other NSAIDs, there is a slight risk of nephrotoxicity with
chronic use.
Fatalities resulting from overdose of ibuprofen alone are rare.
20-70 ug/mL
Neither a therapeutic range nor a toxic level have been established
for ibuprofen. For individuals being dosed within the adult recommended
range of 1.2-3.6 g/day, the expected serum concentration is 20-70 ug/mL.
No significant cautionary statements
Kantor TG: Ibuprofen. Ann Intern Med 1979;91:877-882